A Japanese consortium was launched to promote domestic research and development of cannabis-derived medicines, a field that had opened to approved products after the December 2024 reform. The launch was reported on 14 May 2025, when domestic research in the field was still described as being in its infancy.[1]
Listed for context. No score change is recorded for Japan here.
References
- Pharma Japan — Japan Consortium to Promote Domestic R&D of Cannabis-Derived Meds14 May 2025; lead paragraphsarchived
Checked. The date and the event were compared with a source that was read.